[go: up one dir, main page]

CO7131352A2 - Composiciones farmacéuticas tópicas - Google Patents

Composiciones farmacéuticas tópicas

Info

Publication number
CO7131352A2
CO7131352A2 CO14251765A CO14251765A CO7131352A2 CO 7131352 A2 CO7131352 A2 CO 7131352A2 CO 14251765 A CO14251765 A CO 14251765A CO 14251765 A CO14251765 A CO 14251765A CO 7131352 A2 CO7131352 A2 CO 7131352A2
Authority
CO
Colombia
Prior art keywords
pharmaceutical compositions
topical pharmaceutical
compositions
topical
onychomycosis
Prior art date
Application number
CO14251765A
Other languages
English (en)
Inventor
Dirk-Heinrich Evers
Sabine Fielhauer
Sascha Gorissen
Michael Herbig
Henning Mallwitz
Christoph Willers
Original Assignee
Almirall Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46148606&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO7131352(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Almirall Sa filed Critical Almirall Sa
Publication of CO7131352A2 publication Critical patent/CO7131352A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composiciones farmacéuticas tópicas que comprenden terbinafina y urea, y el uso de dichas composiciones en el tratamiento tópico enfermedades fúngicas, como por ejemplo onicomicosis. Las composiciones que se preveen son estables y muestran una fuerte hidrtación y penetración en la uña.
CO14251765A 2012-05-14 2014-11-13 Composiciones farmacéuticas tópicas CO7131352A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261646650P 2012-05-14 2012-05-14
EP20120003791 EP2664327A1 (en) 2012-05-14 2012-05-14 Topical pharmaceutical compositions comprising terbinafide and urea

Publications (1)

Publication Number Publication Date
CO7131352A2 true CO7131352A2 (es) 2014-12-01

Family

ID=46148606

Family Applications (1)

Application Number Title Priority Date Filing Date
CO14251765A CO7131352A2 (es) 2012-05-14 2014-11-13 Composiciones farmacéuticas tópicas

Country Status (20)

Country Link
US (1) US20150111971A1 (es)
EP (2) EP2664327A1 (es)
JP (1) JP2015516455A (es)
KR (1) KR20150013162A (es)
CN (1) CN104302281A (es)
AR (1) AR091039A1 (es)
AU (1) AU2013261918A1 (es)
BR (1) BR112014028280A2 (es)
CA (1) CA2872210A1 (es)
CL (1) CL2014003081A1 (es)
CO (1) CO7131352A2 (es)
EA (1) EA201492091A1 (es)
HK (1) HK1202808A1 (es)
IL (1) IL235241A0 (es)
MX (1) MX2014013851A (es)
PH (1) PH12014502512A1 (es)
SG (1) SG11201407536UA (es)
TW (1) TW201350107A (es)
WO (1) WO2013171159A1 (es)
ZA (1) ZA201407655B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201317005D0 (en) * 2013-09-25 2013-11-06 Blueberry Therapeutics Ltd Composition and methods of treatment
CN113368215A (zh) 2014-10-21 2021-09-10 赫希玛有限公司 一种治疗方法
GB201605127D0 (en) * 2016-03-25 2016-05-11 Blueberry Therapeutics Ltd Composition and methods of treatment
IL268720B2 (en) * 2017-02-15 2024-09-01 Botanix Pharmaceuticals Ltd Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases
EP3492068A1 (en) 2017-12-01 2019-06-05 NCP NewCare Products GmbH Composition for treating onychomycosis
WO2019214838A1 (en) * 2018-05-09 2019-11-14 Eviderm Institute Ab Use of an alcohol-containing composition for improving the skin barrier function
PL245223B1 (pl) * 2019-01-10 2024-06-03 Biotts Spolka Akcyjna Nośnik farmaceutyczny dla substancji czynnych oraz kompozycja farmaceutyczna go zawierająca
JP6591100B1 (ja) * 2019-01-25 2019-10-16 ロート製薬株式会社 爪及び爪周り用医薬組成物
EP4572746A1 (en) * 2022-08-17 2025-06-25 Lyotropic Delivery Systems Ltd. Topical delivery of antifungal agents for treating fungal infections
KR102597564B1 (ko) * 2023-03-03 2023-11-03 장병모 조갑 및 피부 백선의 예방 또는 치료용 약학적 조성물
EP4470526A3 (en) 2023-07-25 2025-01-15 MiM Pharma GmbH Topical composition for administration to nails

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6281239B1 (en) * 2000-04-12 2001-08-28 Bradley Pharmeaceuticals, Inc. Method of treating onychomycosis
WO2011014850A2 (en) * 2009-07-31 2011-02-03 Nuvo Research Inc. Topical eutectic-based formulations
EP2544659A2 (en) * 2009-12-23 2013-01-16 Nuvo Research Inc. Highly permeating terbinafine formulation for treating onychomycosis

Also Published As

Publication number Publication date
BR112014028280A2 (pt) 2019-09-24
CL2014003081A1 (es) 2015-03-27
US20150111971A1 (en) 2015-04-23
AU2013261918A1 (en) 2014-11-06
JP2015516455A (ja) 2015-06-11
EP2849739A1 (en) 2015-03-25
AR091039A1 (es) 2014-12-30
CN104302281A (zh) 2015-01-21
KR20150013162A (ko) 2015-02-04
MX2014013851A (es) 2015-02-12
EA201492091A1 (ru) 2015-03-31
WO2013171159A1 (en) 2013-11-21
EP2664327A1 (en) 2013-11-20
PH12014502512A1 (en) 2014-12-22
IL235241A0 (en) 2014-12-31
TW201350107A (zh) 2013-12-16
ZA201407655B (en) 2015-06-24
SG11201407536UA (en) 2014-12-30
HK1202808A1 (en) 2015-10-09
CA2872210A1 (en) 2013-11-21

Similar Documents

Publication Publication Date Title
CO7131352A2 (es) Composiciones farmacéuticas tópicas
MX2018004475A (es) Agentes biologicos y su uso en plantas.
GT201400043A (es) Imidazopiridazinas sustituidas con amino
BR112016026291A2 (pt) Derivados do ácido borônico e usos terapêuticos dos mesmos
CL2019001940A1 (es) Composiciones antimicrobianas y métodos de uso relacionados (divisional de solicitud 2519-2015).
CU20120161A7 (es) 5-fluoro-1h-pirazolopiridinas sustituidas
CL2015003801A1 (es) Formulaciones de anticuerpos y metodos
UY33598A (es) Imidazopiridazinas sustituidas
CO2018000350A2 (es) Forma cristalina de la plinabulina monohidratada, composiciones que la comprenden y procedimientos de elaboración
CL2015002433A1 (es) Imidazopiridazinas sustituidas
MX2015012273A (es) Composicion farmaceutica para el tratamiento de infecciones micoticas.
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.
CO6660486A2 (es) Composición tópica famacéutica o cosmética útil para el tratamiento de enfermedades o condiciones que cursan con un déficit de la maduración de la envoltura córnea
MX349854B (es) Composiciones antitranspirantes y metodo para reducir la transpiracion.
CL2015001748A1 (es) Formulaciones antiparasitarias transdermicas
BR112014031706A8 (pt) Composições farmacêuticas orais, e composição farmacêutica oral compreendendo itraconazol
CL2015002191A1 (es) Composición antifúngica tópica para el tratamiento de onicomicosis.
CL2015001502A1 (es) Composición farmacéutica que comprende desloratadina y prendnisolona y uso de la misma.
PE20121537A1 (es) Combinacion de teobromina con un descongestivo
UY35695A (es) Composicion para el tratamiento contra el envejecimiento de la piel
CL2013003588A1 (es) Composicion farmaceutica en forma de suspension oral que comprende como principio activo una fraccion de flavonoide y como excipiente goma de xantano en la cantidad de 0,30 %p/p a 0,60 %p/p; uso para el tratamiento de la insuficiencia venosa.
PE20150869A1 (es) Tris-(hetero)aril-pirazoles y su uso
CR20160116A (es) Método para tratar onicomicosis con hidroxipropil quitasano
PE20150022A1 (es) Dronedarona para uso en la leishmaniosis, formulaciones y asociaciones para uso en la leishmaniosis
BR112013013276A2 (pt) processo para produzir couro, couro, formulação aquosa, e uso da mesma